Dan Peer, Ph.D., Tel Aviv University, Israel and Eran Elinav, M.D., Ph.D., Tel Aviv Sourasky Medical Center, Israel, ($100,000) for their research project, Harnessing Immuno-nanotechnology for Therapy of Inflammatory Bowel Disease.
David Boone, Ph.D., University of Chicago, IL, ($100,000) for his research project, Gastric Control of Intestinal Function.
Gautam Dantas, Ph.D., Washington University School of Medicine, St. Louis, MO, ($100,000) for his research project, Synthetic Engineering of Enhanced Fitness and Adhesion Properties in Probiotics for the treatment of Inflammatory Bowel Disease.
Gwendalyn Randolph, Ph.D., Washington University, St. Louis, MO, ($100,000) for her project, Interface Between Antigen-Presenting Cells, Lympahtics, and the Expansion of Adipose Tissue in Inflammatory Intestinal Disease.
Richard M. Maizels, Ph.D., Edinburgh University, UK, ($100,000) for his research project, Potential of Parasite Products to Suppress Inflammatory Bowel Disease.
Samuel L. Miller, M.D., University of Washington, Seattle, WA, ($100,000) for his research project, Development of a Fecal Microbiota Transplant Mouse Model for Ulcerative Colitis to Identify Pro-and Anti-inflammatory Bacteria.
Thaddeus S. Stappenbeck M.D., Ph.D. and Herbert W. Virgin, IV, Washington University Medical School, St. Louis, MO, ($100,000) for their research project, Identification of Microbial Triggers of Colitis in Genetically relevant, Transmissible Mouse Model.
Tiffany Horng, Ph.D., Assistant Professor, Department of Genetics and Complex Diseases, Harvard School of Public Health, Boston, MA, ($100,000) for her project, A Novel Mouse Model to Study the Molecular Basis of Chronic Inflammation in Inflammatory Bowel Disease.